Core V2 completely unleashes the imagination for re-staking—insurance, credit, and RWA can all be integrated, and idle funds can still earn yield through Aave. This is the real capital efficiency.

Re-staking protocol Symbiotic announced the launch of Core V2, expanding its shared collateral mechanism to scenarios including insurance, on-chain credit, and RWA. Core V2 allows the same collateral asset to support multiple financial obligations at the same time, and deploys it to protocols such as Aave and Morpho during idle periods to generate additional yield. Symbiotic said the upgrade is designed to build an on-chain “Collateral Markets” framework, improve capital efficiency, and bring institutional capital into on-chain finance. Symbiotic previously raised $5.8 million in a seed round led by Paradigm in 2024, and completed a $29 million funding round led by Pantera Capital in 2025.